Viridos’ plan is to create renewable energy through the use of microalgae to create the kind of dense, resource-intensive fuel that powers airplanes and large-scale shipping operations. The technology Viridos is developing is important because […]
LONDON (Reuters) – UK investors backed money market funds in May at the fastest rate since the country’s failed ‘mini-budget’ last year, opting for caution after a volatile period in global banking, funds network Calastone […]
(Bloomberg) — For an illustration of how wildly different the debate around ESG is in Europe and the US, look no further than the German state of Baden-Württemberg. One of the richest regions in Europe’s […]
The global ESG movement took a hit this week, as an investor-driven climate change push at some of the world’s leading fossil fuel companies fell well short of the mark. On 31 May, shareholders at Exxon and […]
Critics like to paint ethical and green investing as a form of socialism, but buying assets to influence them is a sign of a functioning free market. Sitting in the audience at The Australian Financial Review […]
Southern California investors sometimes ask financial planner Mitchell Kraus, with Santa Monica-based Capital Intelligence Associates, to make sure they aren’t backing gun makers or for-profit prisons. But by far, Kraus said, the most common request […]
The Dow Jones fell slightly in Monday morning trading, while the S&P 500 index and Nasdaq composite edged higher following last week’s big gains. Crude oil prices rose on a surprise Saudi Arabia production cut. […]
Each month, the IBD/TIPP Poll, a collaboration between Investor’s Business Daily and TechnoMetrica, produces an exclusive Presidential Leadership Index. In addition to tracking President Joe Biden’s job approval rating, the index combines results from several […]
President Joe Biden’s approval rating has fallen to its worst level of 2023 as younger voters, who will be key to his reelection chances, turn lukewarm, the new IBD/TIPP Poll finds. The June IBD/TIPP Poll […]
ImmunoGen (IMGN) and Day One Biopharmaceuticals (DAWN) unveiled promising cancer treatment updates over the weekend, leading IMGN stock and DAWN stock to soar Monday. Both updates came during the American Society of Clinical Oncology annual […]
Copyright © 2026 | Sandstone Group